CUSIP: 249827502
Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM PAR $.01
-
Total 13F shares
-
21,720,105
-
Share change
-
-455,801
-
Total reported value
-
$251,081,856
-
Put/Call ratio
-
25%
-
Price per share
-
$11.56
-
Number of holders
-
71
-
Value change
-
-$7,514,802
-
Number of buys
-
40
-
Number of sells
-
30
Quarterly Holders Quick Answers
What is CUSIP 249827502?
CUSIP 249827502 identifies DSCI - DERMA SCIENCES INC - COM PAR $.01 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2014
-
Previous quarter:
Q1 2014
Recent filing periods for CUSIP 249827502:
Institutional Holders of DERMA SCIENCES INC - COM PAR $.01 (DSCI) as of Q2 2014
As of 30 Jun 2014,
DERMA SCIENCES INC - COM PAR $.01 (DSCI) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,720,105 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, Broadfin Capital, LLC, Consonance Capital Management LP, GREAT POINT PARTNERS LLC, JENNISON ASSOCIATES LLC, JPMORGAN CHASE & CO, HealthCor Management, L.P., MANUFACTURERS LIFE INSURANCE COMPANY, THE, and THOMSON HORSTMANN & BRYANT INC.
This page lists
71
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.